Compugen Ltd. (NASDAQ:CGEN) Reaches New 1-Year Low at $3.10

Compugen Ltd. (NASDAQ:CGEN) hit a new 52-week low on Thursday . The company traded as low as $3.10 and last traded at $3.15, with a volume of 69,191 shares changing hands. The stock had previously closed at $3.35.

A number of equities research analysts have recently weighed in on CGEN shares. Zacks Investment Research downgraded Compugen from a “hold” rating to a “sell” rating in a report on Monday, May 22nd. FBR & Co set a $14.00 price target on Compugen and gave the company a “buy” rating in a report on Friday, May 19th.

The company’s market capitalization is $158.51 million. The stock’s 50-day moving average price is $3.75 and its 200-day moving average price is $4.20.

Compugen (NASDAQ:CGEN) last issued its earnings results on Wednesday, August 2nd. The biotechnology company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.17) by $0.01. Compugen had a negative return on equity of 57.69% and a negative net margin of 4,425.00%. Equities research analysts forecast that Compugen Ltd. will post ($0.73) earnings per share for the current fiscal year.

Several institutional investors have recently modified their holdings of CGEN. Benjamin F. Edwards & Company Inc. boosted its position in shares of Compugen by 5.7% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 66,300 shares of the biotechnology company’s stock worth $285,000 after buying an additional 3,600 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Compugen by 38.7% in the first quarter. Goldman Sachs Group Inc. now owns 59,797 shares of the biotechnology company’s stock worth $257,000 after buying an additional 16,696 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in shares of Compugen by 522.2% in the first quarter. Tower Research Capital LLC TRC now owns 23,576 shares of the biotechnology company’s stock worth $101,000 after buying an additional 19,787 shares during the last quarter. Vident Investment Advisory LLC boosted its position in shares of Compugen by 20.0% in the first quarter. Vident Investment Advisory LLC now owns 150,614 shares of the biotechnology company’s stock worth $648,000 after buying an additional 25,100 shares during the last quarter. Finally, Renaissance Technologies LLC boosted its position in shares of Compugen by 8.7% in the first quarter. Renaissance Technologies LLC now owns 581,236 shares of the biotechnology company’s stock worth $2,499,000 after buying an additional 46,336 shares during the last quarter. 19.37% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Compugen Ltd. (NASDAQ:CGEN) Reaches New 1-Year Low at $3.10” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2798781/compugen-ltd-nasdaqcgen-reaches-new-1-year-low-at-3-10.html.

Compugen Company Profile

Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company’s pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates.

Receive News & Ratings for Compugen Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugen Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.